V. Matiychuk

Novel N-(4-thiocyanatophenyl)-1H-1,2,3-triazole-4-carboxamides exhibit selective cytotoxic activity at nanomolar doses towards human leukemic T-cells.

N. Finiuk, R. Stoika, N. Pokhodylo, 2022, European journal of medicinal chemistry.

Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives

V. Poroikov, A. Geronikaki, A. Petrou, 2022, Molecules.

Primary discovery of 1-aryl-5-substituted-1H-1,2,3-triazole-4-carboxamides as promising antimicrobial agents

N. Finiuk, R. Stoika, N. Pokhodylo, 2021 .

Synthesis of 3‐Aryl/methoxycarbonyl‐3,4‐dihydroisocoumarin‐6‐carboxylic Acid Derivatives

M. Obushak, Y. Ostapiuk, V. Matiychuk, 2014 .

Bioisosteric replacement of 1H-1,2,3-triazole with 1H-tetrazole ring enhances anti-leukemic activity of (5-benzylthiazol-2-yl)benzamides.

N. Finiuk, R. Stoika, N. Pokhodylo, 2023, European journal of medicinal chemistry.

Synthesis and anticancer activity evaluation of new 1,2,3-triazole-4-carboxamide derivatives

N. Pokhodylo, O. Shyyka, V. Matiychuk, 2014, Medicinal Chemistry Research.

5-(1 H -Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)alkancarboxylic Acids as Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies

A. Geronikaki, A. Petrou, A. Ćirić, 2020 .